LOGIN  |  REGISTER
Terns Pharmaceuticals

Recent Insider Transactions - PTC Therapeutics (NASDAQ: PTCT)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ PTCT PTC Therapeutics
Boulding Mark Elliott / officer: EXEC. VP AND CLO
08/15/2025
Buy
$25.69
2,813
$72K
106,714
NASDAQ PTCT PTC Therapeutics
Boulding Mark Elliott / officer: EXEC. VP AND CLO
08/15/2025
Sell
$48.58
2,813
$137K
103,901
NASDAQ PTCT PTC Therapeutics
Boulding Mark Elliott / officer: EXEC. VP AND CLO
08/15/2025
Sell
$25.69
2,813
$72K
24,899
NASDAQ PTCT PTC Therapeutics
Klein Matthew B. / director, officer: CHIEF EXECUTIVE OFFICER
08/05/2025
Sell
$51.74
10,739
$556K
337,767
NASDAQ PTCT PTC Therapeutics
Gravier Pierre / officer: CHIEF FINANCIAL OFFICER
07/15/2025
Sell
$49.46
2,516
$124K
71,920